260 related articles for article (PubMed ID: 22447497)
21. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
[TBL] [Abstract][Full Text] [Related]
23. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
Rzeppa S; Viet LN
Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
[TBL] [Abstract][Full Text] [Related]
24. The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.
Haase CB; Backer V; Kalsen A; Rzeppa S; Hemmersbach P; Hostrup M
Drug Test Anal; 2016 Jul; 8(7):613-20. PubMed ID: 26044066
[TBL] [Abstract][Full Text] [Related]
25. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
26. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
27. Ultraperformance liquid chromatography tandem mass spectrometric method for direct quantification of salbutamol in urine samples in doping control.
Ventura R; Ramírez R; Monfort N; Segura J
J Pharm Biomed Anal; 2009 Dec; 50(5):886-90. PubMed ID: 19596537
[TBL] [Abstract][Full Text] [Related]
28. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
[TBL] [Abstract][Full Text] [Related]
29. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
[TBL] [Abstract][Full Text] [Related]
30. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
[TBL] [Abstract][Full Text] [Related]
31. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose.
Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D
Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556
[TBL] [Abstract][Full Text] [Related]
32. Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry.
Mareck U; Guddat S; Schwenke A; Beuck S; Geyer H; Flenker U; Elers J; Backer V; Thevis M; Schänzer W
Drug Test Anal; 2011; 3(11-12):820-7. PubMed ID: 22081503
[TBL] [Abstract][Full Text] [Related]
33. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
[TBL] [Abstract][Full Text] [Related]
34. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
Ahrens BD; Kucherova Y; Butch AW
Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
[TBL] [Abstract][Full Text] [Related]
35. Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry.
Touber ME; van Engelen MC; Georgakopoulus C; van Rhijn JA; Nielen MW
Anal Chim Acta; 2007 Mar; 586(1-2):137-46. PubMed ID: 17386705
[TBL] [Abstract][Full Text] [Related]
36. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
[TBL] [Abstract][Full Text] [Related]
37. Analysis of β-agonists by HPLC/ESI-MS(n) in horse doping control.
Garcia P; Paris AC; Gil J; Popot MA; Bonnaire Y
Biomed Chromatogr; 2011 Jan; 25(1-2):147-54. PubMed ID: 21204111
[TBL] [Abstract][Full Text] [Related]
38. Screening for benfluorex and its major urinary metabolites in routine doping controls.
Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W
Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611
[TBL] [Abstract][Full Text] [Related]
39. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes.
Mazzarino M; Cesarei L; de la Torre X; Fiacco I; Robach P; Botrè F
J Pharm Biomed Anal; 2016 Jan; 117():47-60. PubMed ID: 26342446
[TBL] [Abstract][Full Text] [Related]
40. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry.
Deventer K; Eenoo PV; Delbeke FT
Biomed Chromatogr; 2006 May; 20(5):429-33. PubMed ID: 16177960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
